Nutriband OCPMR Bond
Nutriband holds a debt-to-equity ratio of 0.021. With a high degree of financial leverage come high-interest payments, which usually reduce Nutriband's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Nutriband's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Nutriband's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Nutriband Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Nutriband's stakeholders.
For most companies, including Nutriband, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Nutriband, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Nutriband's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Nutriband |
| Popular Name | Nutriband OCPMR 45 22 OCT 25 |
| Specialization | Biotechnology |
| Equity ISIN Code | US67092M2089 |
| Bond Issue ISIN Code | US67091TAC99 |
Nutriband Outstanding Bond Obligations
| OCPMR 5125 23 JUN 51 | US67091TAE55 | Details | |
| OCPMR 45 22 OCT 25 | US67091TAC99 | Details | |
| OCPMR 375 23 JUN 31 | US67091TAD72 | Details |
Understaning Nutriband Use of Financial Leverage
Nutriband's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Nutriband's total debt position, including all outstanding debt obligations, and compares it with Nutriband's equity. Financial leverage can amplify the potential profits to Nutriband's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Nutriband is unable to cover its debt costs.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Nutriband operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. Please read more on our technical analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Tools for Nutriband Stock
When running Nutriband's price analysis, check to measure Nutriband's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutriband is operating at the current time. Most of Nutriband's value examination focuses on studying past and present price action to predict the probability of Nutriband's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutriband's price. Additionally, you may evaluate how the addition of Nutriband to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.